244 related articles for article (PubMed ID: 22988297)
21. Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Zeng H; Jorapur A; Shain AH; Lang UE; Torres R; Zhang Y; McNeal AS; Botton T; Lin J; Donne M; Bastian IN; Yu R; North JP; Pincus L; Ruben BS; Joseph NM; Yeh I; Bastian BC; Judson RL
Cancer Cell; 2018 Jul; 34(1):56-68.e9. PubMed ID: 29990501
[TBL] [Abstract][Full Text] [Related]
22. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
[TBL] [Abstract][Full Text] [Related]
23. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
24. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
25. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
[TBL] [Abstract][Full Text] [Related]
26. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.
Boyle GM; Woods SL; Bonazzi VF; Stark MS; Hacker E; Aoude LG; Dutton-Regester K; Cook AL; Sturm RA; Hayward NK
Pigment Cell Melanoma Res; 2011 Jun; 24(3):525-37. PubMed ID: 21435193
[TBL] [Abstract][Full Text] [Related]
27. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
29. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
Nat Commun; 2013; 4():1508. PubMed ID: 23443536
[TBL] [Abstract][Full Text] [Related]
30. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
31. Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma?
Blake J; Ziman MR
Histol Histopathol; 2003 Apr; 18(2):529-39. PubMed ID: 12647804
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PAX3 by TGF-beta modulates melanocyte viability.
Yang G; Li Y; Nishimura EK; Xin H; Zhou A; Guo Y; Dong L; Denning MF; Nickoloff BJ; Cui R
Mol Cell; 2008 Nov; 32(4):554-63. PubMed ID: 19026785
[TBL] [Abstract][Full Text] [Related]
33. PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans.
He S; Yoon HS; Suh BJ; Eccles MR
J Invest Dermatol; 2010 May; 130(5):1465-8. PubMed ID: 20107488
[No Abstract] [Full Text] [Related]
34. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
Silva JM; Bulman C; McMahon M
Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
[TBL] [Abstract][Full Text] [Related]
35. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.
Khalili JS; Yu X; Wang J; Hayes BC; Davies MA; Lizee G; Esmaeli B; Woodman SE
Clin Cancer Res; 2012 Aug; 18(16):4345-55. PubMed ID: 22733540
[TBL] [Abstract][Full Text] [Related]
36. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.
Thomson JA; Murphy K; Baker E; Sutherland GR; Parsons PG; Sturm RA; Thomson F
Oncogene; 1995 Aug; 11(4):691-700. PubMed ID: 7651733
[TBL] [Abstract][Full Text] [Related]
37. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways.
Liang G; Liu M; Wang Q; Shen Y; Mei H; Li D; Liu W
Oncotarget; 2017 Apr; 8(17):28510-28525. PubMed ID: 28212537
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of oncogenic BRAF activity by indole-3-carbinol disrupts microphthalmia-associated transcription factor expression and arrests melanoma cell proliferation.
Kundu A; Quirit JG; Khouri MG; Firestone GL
Mol Carcinog; 2017 Jan; 56(1):49-61. PubMed ID: 26878440
[TBL] [Abstract][Full Text] [Related]
39. IGF-1 promotes Brn-4 expression and neuronal differentiation of neural stem cells via the PI3K/Akt pathway.
Zhang X; Zhang L; Cheng X; Guo Y; Sun X; Chen G; Li H; Li P; Lu X; Tian M; Qin J; Zhou H; Jin G
PLoS One; 2014; 9(12):e113801. PubMed ID: 25474202
[TBL] [Abstract][Full Text] [Related]
40. PAX3 and SOX10 activate MET receptor expression in melanoma.
Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]